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Hantavirus Infection 
with Marked Sinus 
Bradycardia, Taiwan
To the Editor: Hantaviruses are
enveloped RNA viruses belonging to
the family Bunyaviridae  (1,2), for
which a number of species have been
identified, including the Hantaan,
Seoul, Puumala, Dobrava-Belgrade,
and Sin Nombre viruses (1,2). Each
hantavirus is associated with a specific
rodent reservoir (1,2). Hantaan virus,
found throughout northeastern Asia,
causes a life-threatening illness known
as hemorrhagic fever with renal syn-
drome (HFRS). Main symptoms and
signs of HFRS are fever, myalgia,
severe vascular leakage with ascites
and retroperitoneal edema and pain
(abdominal, loin, or headache), shock,
acute renal failure, proteinuria and
hematuria, thrombocytopenia, and
bleeding complications (3). Seoul
virus, found worldwide, and Puumala
virus, found in Scandinavia and East-
ern Europe, cause mild forms of
HFRS. Sin Nombre virus, found in the
United States, causes hantavirus pul-
monary syndrome, which is character-
ized by increased pulmonary capillary
permeability and pulmonary edema
and can progress to severe respiratory
distress syndrome and shock as a
result of low cardiac output (4,5).
Despite the fact that HFRS is fre-
quently reported in People’s Republic
of China, no indigenous cases of
HFRS have been reported in Taiwan.
Previous serologic studies found that
the Seoul strain is endemic in the areas
of Taiwan and two isolated islands
nearby, Kinmen and Matzu; in con-
trast, in the People’s Republic of
China, the Hantaan and Seoul strains
concurrently predominate (6,7).
Our patient, a 38-year-old man,
had onset of sore throat, headache,
cough, myalgia, and intermittent fever
(up to 38.3°C) on February 2, 2001. A
resident of Matzu for more than 30
years, he had traveled to the People’s
Republic of China 3 months before the
symptoms began. Laboratory tests at a
local hospital showed thrombocytope-
nia (58,000/mL) and leukopenia
(3,800/mL). Because his symptoms
persisted, he was transferred to the
National Taiwan University Hospital
on February 7, 2001. Initial tests there
showed a temperature of 36.4°C, heart
rate 74 beats/min, and respiratory rate
18/min; there was no skin rash. The
rest of the physical examination was
normal. He had a platelet count
73,000/µL; leukocytes 5,670/µL with
59.1% segments, 19.8% lymphocytes,
and 18.2% monocytes; urea nitrogen
7.4 mg/dL; and creatinine 0.94 mg/dL.
Urinalysis showed proteinuria (300
mg/dL). His chest radiography was
normal. Abdominal ultrasound
showed a fatty liver.
After admission, the patient’s lab-
oratory values gradually improved and
his proteinuria subsided. He had no
fever. On February 10, 2001, he had
marked sinus bradycardia (as low as
33 beats/min) and became fatigued.
His blood pressure was 120–130/70–
80 mmHg. No abnormal serum elec-
trolytes, urea nitrogen, creatinine, cre-
atine kinase, and troponin-I were
noted. Echocardiogram showed nor-
mal atrium and ventricle size, good
left ventricle contractility, and small
amount of pericardial effusion. His
heart rate gradually increased. He was
discharged on February 15, 2001,
without event. 
A substantial increase of serum
immunofluorescent immunoglobulin
(Ig) G titers (1:640 on February 6;
1:5120 on February 19, 2001) and
positive IgM titers of 1:80 against
hantavirus antigen (Seoul type) con-
firmed that this virus was responsible
for the illness.
A few reports of hantavirus infec-
tion with cardiac involvement have
been published. A case report by Chun
and Godfrey showed right atrium dila-
tion with diffuse atrial hemorrhage,
interstitial edema, and vascular con-
gestion without surrounding myocar-
dial fibers and conduction system
involvement in a 19-year-old soldier
who died from epidemic (Korean)
hemorrhagic fever, sinus tachycardia,
paroxysmal supraventricular tachycar-
dia, and congestive heart failure (8).
Marked sinus bradycardia (as low as
34 beats/min) in a patient with a
severe form of hemorrhagic fever with
renal syndrome (acute renal failure)
has been reported (9). However, this
finding was not observed in patients
with mild cases of the disease.
The possibility that our patient
acquired the infection during his travel
to the People’s Republic of China 3
months earlier is extremely low
because of the length of the incubation
period (typical incubation period 4–28
days) (10) and the different hantavirus
strains prevalent in the People’s
Republic of China (6). Although viral
genetic sequence data from the patient
and rodents in Matzu were not avail-
able in this study, our patient was
infected with the Seoul strain, which is
highly seroprevalent in rodents in
Matzu (6,7).  
In summary, this case was probably
the first indigenous case of hantavirus
infection in Taiwan. Its characteristics
suggest that marked sinus bradycardia
should be included as a protean mani-
festation of hantavirus.
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Public Meeting: Annual Report on 
Antimicrobial Resistance Action Plan
Bethesda, Maryland
June 26, 2002
A public meeting will be held on June 26, 2002, from 10:00 a.m. to 5:00 p.m., to present the first annual report on
implementation of A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues) and to
receive comments from the public. This plan was prepared by the Interagency Task Force on Antimicrobial Resistance,
which is co-chaired by CDC, FDA, and NIH and includes seven other Federal agencies and departments. The meeting will
be at the Holiday Inn Select, Versailles Ballroom, 8120 Wisconsin Avenue, Bethesda, Maryland, 20814; Toll-Free:1-877-
888-3001.
Time will be available for oral questions, comments, and suggestions from the public. In the interest of time, a limit of
three minutes may be imposed and visual aids will not be permitted. However, written comments and suggestions for sub-
sequent review by the Task Force are encouraged and can be submitted through July 31, 2002 to either of the addresses
given below.
The Action Plan and meeting agenda are available at http://www.cdc.gov/drugresistance; the Annual Report will be
posted when available, likely in early June. Anyone planning to attend the meeting should contact Ms. Vickie Garrett,
Antimicrobial Resistance, CDC, 1600 Clifton Rd., MS C-12, Atlanta, GA 30333; telephone 404-639-2603; fax 404-639-
4197 or should e-mail aractionplan@cdc.gov by June 22, 2002. Please include name, organization (if applicable), address,
phone, fax, and e-mail address.